We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-21.87%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$70.4M
AUM Growth
-$34.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHL
1
DELISTED
Achilles Therapeutics
ACHL
$27.9M 39.7%
11,086,909
AUTL
2
Autolus Therapeutics
AUTL
$386M
$20.8M 29.54%
7,346,829
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$19.3M 27.43%
1,466,508
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$2.34M 3.33%
1,377,294

Similar funds

Syncona Portfolio's Q2 2022 Portfolio in Review

As of Q2 2022, Syncona Portfolio held 4 positions worth $70.4M, down 33% from $105M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Syncona Portfolio opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's ten largest holdings make up 100% of its $70.4M portfolio in Q2 2022.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q2 2022.
  • Syncona Portfolio's portfolio value fell 33% quarter-over-quarter to $70.4M.

Based on Syncona Portfolio's 13F filing for Q2 2022, filed 10 Aug 2022.